RIPC improves diabetic control in type 2 diabetes mellitus

Effect of remote ischaemic preconditioning on diabetic control in type 2 diabetes mellitus - RIPC-GENESIS Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs032190050

Enrollment

Registered

2019-07-03

Start date

2019-08-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

Use of nitric oxide production equipment for 5 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients with HbA1c >=7.0%

Exclusion criteria

Exclusion criteria: Patients with repeated severe hypoglycemia and/or malignant tomors and/or peripheral artery disease and/or pregnancy

Design outcomes

Primary

Measure	Time frame
GA(glycoalbumin)	—

Secondary

Measure	Time frame
PG(plasma glucose),HbA1c,FGM data(mean glucose, standard deviation, coefficient of variation, MAGE, AUC >180, and AOC<70)	—

Contacts

Public ContactTakeshi Oba

Graduate School of Medicine, Nippon Medical School

t-ooba@nms.ac.jp+81-3-5814-6267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026